Elsa Renee Flores

552 posts

Elsa Renee Flores banner
Elsa Renee Flores

Elsa Renee Flores

@LabElsaFlores

Moffitt Cancer Center ACD & Division Chief, Basic Science. Cancer Biologist. Discovery Science.

Tampa, FL Katılım Şubat 2020
1.1K Takip Edilen746 Takipçiler
Elsa Renee Flores retweetledi
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
From the floor at #AACR26, a conversation between Elsa Flores, PhD (@LabElsaFlores), and Chang Jiang, PhD (@ChangJiangLab), on how cancer metabolism research, including dendritic cell metabolism, may enhance immune responses and improve therapies like CAR T-cell treatment. #MoffittAACR26 @AACR
English
0
12
23
1K
Elsa Renee Flores retweetledi
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
Earlier at #AACR26, Elsa Flores, PhD (@LabElsaFlores), and Andrii Monastyrskyi, PhD, took a moment to discuss how emerging drug discovery approaches, including protein degradation and AI-driven design, are advancing new cancer therapies. #MoffittAACR26 @AACR
English
0
9
20
930
Gomes Lab
Gomes Lab@lab_gomes·
Honored to be recognized as the Research Educator of the Year. A PI’s real legacy isn’t just the papers they publish or the grants they win, it’s the people they mentor, the scientists, thinkers, and leaders who carry forward the values, curiosity, and rigor they helped cultivate
Gomes Lab tweet mediaGomes Lab tweet media
English
3
6
58
2.7K
Elsa Renee Flores
Elsa Renee Flores@LabElsaFlores·
This morning, I was thrilled to show off the progress on the Moffitt Discovery and Innovation Center at SPEROS. I can’t wait to make new discoveries with my colleagues using trans disciplinary approaches. Big thank you to @PatrickHwuMD @HLeeMoffitt1 @john Cleveland for the opportunity to lead this effort! @MoffittNews
Elsa Renee Flores tweet mediaElsa Renee Flores tweet mediaElsa Renee Flores tweet mediaElsa Renee Flores tweet media
English
0
2
17
375
Elsa Renee Flores retweetledi
AACR
AACR@AACR·
James V. DeGregori, Emilia Lim, William Hill, and Kenneth Y. Tsai discussed "Early Events and Clonal Origins" in a plenary session at the AACR Special Conference on Cancer Evolution. #AACRevol25 @LimEmilia @DrWilliamHill @KYTsaiLab
AACR tweet media
English
1
3
12
1.7K
Elsa Renee Flores retweetledi
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
At #SITC25, Kenneth Tsai, MD (@KYTsaiLab), presents Phase II results showing a 57.7% pCR with neoadjuvant lenvatinib plus pembrolizumab in stage II–IV Merkel cell carcinoma. Responders show interferon and ANGPTL1 signaling; nonresponders show neural and E2F/MYC pathways with higher baseline Tregs. #MoffittSITC25
English
0
3
7
667
Elsa Renee Flores retweetledi
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
Live from #SITC25: Kenneth Tsai, MD (@KYTsaiLab) presents data showing that Pembrolizumab plus Levatinib demonstrated encouraging efficacy as neoadjuvant therapy for resectable clinical stage II-IV Merkel cell carcinoma.
Moffitt Cancer Center tweet mediaMoffitt Cancer Center tweet mediaMoffitt Cancer Center tweet media
English
0
5
9
587
Elsa Renee Flores retweetledi
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
Tomorrow at #SITC25: Kenneth Tsai, MD, PhD (@KYTsaiLab) presents a late-breaking abstract on the molecular and immunologic correlates of response in the phase II study of neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma. #MoffittSITC25 @sitcancer
Moffitt Cancer Center tweet media
English
0
6
10
535

Keşfet

@Ruffell_Lab @AACR @ChangJiangLab @KarrethLab @PatrickHwuMD @MoffittNews @JenBinning @lab_gomes